HOME >> BIOLOGY >> NEWS
New Northwestern center targets brain disorders

combining molecular biology and gene discovery with the pragmatism of engineering in order to solve this problem and others."

The second potential therapy is based on the discovery by Moskal and colleagues of a family of molecules called glyxins that appear to enhance learning and memory. The Food and Drug Administration recently approved the glyxins for human phase I trials.

"The glyxins also may have an impact on attention deficit hyperactivity disorder, memory loss associated with the early stages of Alzheimer's disease as well as normal aging, damage due to stroke, and neuropathic pain," said Moskal. He has collaborated for years with John Disterhoft, professor of physiology at Feinberg, in evaluating the compounds.

Recently, another long-time collaborator, Jaak Panksepp, an emeritus professor in the psychology department at Bowling Green State University, joined the Falk Center as head of its affective neuroscience research program.

The Falk Center puts state-of-the-art gene chip technology -- the same used to discover the glyxins and the brain tumor therapy -- into the hands of Northwestern faculty and students. This technology, used to identify gene targets for new therapeutics, is more often found in the private sector than in universities.

"Very few universities in the country have direct access to gene chip technology of this caliber," said Roger Kroes, chief of molecular neuro-oncology at Falk and assistant research professor of biomedical engineering. "In the Chicago area, only a handful of programs in academia and the private sector combined have facilities equivalent to the Falk Center's."

Moskal and his staff build their own microarrays from scratch and are continually evolving the technology. Now they can train faculty, undergraduate and graduate students, and visiting scholars to build customized gene chips for their own discoveries. Moskal and his staff already have taught a class in advanced mo
'"/>

Contact: Megan Fellman
fellman@northwestern.edu
847-491-3115
Northwestern University
10-Feb-2003


Page: 1 2 3

Related biology news :

1. Northwesterns Cancer Genetics Program pinpoints gene that increases cancer risk by 26 percent
2. Northwestern receives $5.65 million for reproductive research
3. Northwestern launches major gene banking project
4. A little larceny comes naturally to Northwestern crows
5. Northwestern receives $17 million for functional genomics research
6. Northwestern program aims at revealing genetic causes of spina bifida
7. Northwestern researchers map gene mutation that makes mice deaf and causes them to dance
8. Northwestern scientists shed new light on neurodegenerative diseases
9. Northwestern researchers clone gene responsible for inner ear motor
10. Northwestern team identifies first enzyme in mammalian circadian clock
11. Northwestern Hosts Public Forum On Future Of Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/2/2016)... , June 2, 2016 ... Manned Platforms, Unmanned Systems, Physical Infrastructure, Support & Other ... provider visiongain offers comprehensive analysis of the ... this market will generate revenues of $17.98 billion in ... acquired DVTEL Inc, a leader in software and hardware ...
(Date:5/16/2016)... May 16, 2016   EyeLock LLC , a ... the opening of an IoT Center of Excellence in ... expand the development of embedded iris biometric applications. ... of convenience and security with unmatched biometric accuracy, making ... aside from DNA. EyeLock,s platform uses video technology to ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. ... test has received AOAC Research Institute approval 061601. , “This is another AOAC-RI ... stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, the Industry ... Supplyframe Design Lab . Located in Pasadena, Calif., the Design Lab’s mission ... hardware projects are designed, built and brought to market. , The Design Lab ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a ... discoveries to the medical community, has closed its Series ... Matthew Nunez . "We have received a ... the capital we need to meet our current goals," ... provide us the runway to complete validation on the ...
Breaking Biology Technology:
Cached News: